In the world of neonatal care, every second counts. Aulisa® Medical USA, Inc. is transforming infant monitoring with its FDA-cleared Guardian Angel® systems, designed specifically for neonatal patients and trusted by both clinical NICU teams and families at home. As the only company offering wearable, portable monitoring cleared for hospital-at-home use, Aulisa® delivers seamless AI-enhanced care continuity from NICU to nursery for newborns.
For NICU Teams: Centralized Multiple Patient Monitoring System (CMPM)
Designed for hospital environments, Aulisa’s CMPM platform empowers NICU care teams with a centralized dashboard to monitor multiple infants simultaneously—enhancing efficiency, easing staff workload, and enabling early detection and rapid response to vital sign changes for proactive care.
Key Features of CMPM:
· Continuous real-time blood oxygen saturation level (SpO)₂, pulse rate (PR) and body temperature monitoring for multiple patients
· Large-display monitoring from nurse stations or physician offices
· Early detection visual and audible alarms for immediate intervention
· Aulisa® patient monitoring platform driven by proprietary AI-enhanced software + app
· Cost-effective and customizable setup for NICUs
“Our FDA-Cleared CMPM system gives NICUs the tools to scale up monitoring while staying intimately connected to every infant’s vitals,” said Augustine (Augie) Lien, Founder and CEO of Aulisa® Medical.
For Families: Gateway System for Hospital-at-Home Monitoring
When infants leave the NICU, Aulisa’s Guardian Angel® GA1001 Lite with NXP Gateway ensures that critical care doesn’t stop. It’s the only FDA-cleared system that is both wearable and portable—offering second-by-second vitals tracking and customizable alarms from anywhere.
Key Home Monitoring Highlights:
· Wireless, wearable sensor designed for infant comfort
· Measures SpO₂, pulse rate, and body temperature every second
· NXP-powered gateway converts Bluetooth to Wi-Fi for long-distance access
· Real-time data shared with unlimited caregivers via app (iOS/Android)
· Ideal for high-risk infants, post-discharge monitoring, and peace of mind at home
“For parents caring for premature or high-risk newborns, the Guardian Angel® system provides hospital-level oversight in the most comforting place—home,” added Lien. "Aulisa is deeply committed to advancing remote patient monitoring and digital healthcare," said Augustine (Augie) Lien, founder and CEO of Aulisa Medical. "Hospital-at-home care is redefining how we support patients, and our Guardian Angel system provides the critical, real-time insights needed to intervene early and prevent complications."
Built with AI to Empower Smarter Neonatal Care
Across both systems, Aulisa’s technology is powered by over 2 million data points, combined with AI integrations including OpenAI, computer vision, and predictive analytics. The result: early warnings, personalized alerts, and adaptive insights that help caregivers and providers respond faster—and smarter.
“We’re using AI not just to monitor, but to help clinicians and families predict and prevent complications,” said Lien. “This is proactive care made possible through precision technology.”
To learn more about our Guardian Angel® systems, please visit the webpages below or listen to a 5-minute podcast episode.
· NICU & Clinical Monitoring (CMPM)
· Hospital-at-Home Infant Monitoring
5 minute podcast: